Biochemical and pharmacologic studies with 1-β-d-arabinofuranosylcytosine 5′-adamantoate (NSC-117614), a depot form of cytarabine
- 1 December 1971
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 20 (12) , 3295-3308
- https://doi.org/10.1016/0006-2952(71)90434-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Immunosuppressive effects of adamantoyl cytarabine—I: Inhibition of hemagglutinin formation0 and graft versus host reactions in miceBiochemical Pharmacology, 1969
- Studies of the enzymatic deamination of ara-cytidine—V: Inhibition in vitro and in vivo by tetrahydrouridine and other reduced pyrimidine nucleosidesBiochemical Pharmacology, 1968
- Transport and Phosphorylation as Factors in the Antitumor Action of Cytosine ArabinosideScience, 1967
- The Adamantyl Group in Medicinal Agents. III. Nucleoside 5′-Adamantoates. The Adamantoyl Function as a Protecting GroupJournal of Medicinal Chemistry, 1967
- Studies of the enzymatic deamination of cytosine arabinoside—IBiochemical Pharmacology, 1965
- A proposed mechanism of action of 1-β-d-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cellsBiochemical Pharmacology, 1962
- MULTIPLE FORMS OF ESTERASE IN VERTEBRATE BLOOD PLASMA*Annals of the New York Academy of Sciences, 1961
- A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidBiochemical Journal, 1956